https://www.biospace.com/press-releases/unlearn-and-trace-neuroscience-partner-to-optimize-als-clinical-trial
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial - BioSpace
clinical trialunlearntraceneurosciencepartner
https://www.biospace.com/drug-development/als-advances-unite-patients-and-pharma-on-novel-targets-biomarker-breakthroughs
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs - BioSpace
Feb 26, 2026 - In this episode of Denatured, you'll be listening to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY...
https://www.biospace.com/rapid-dose-announces-board-of-director-changes
Rapid Dose Announces Board of Director Changes - BioSpace
Apr 17, 2023 - Rapid Dose Therapeutics Corp., a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is announcing changes to its...
board of directorrapid doseannounceschangesbiospace
https://www.biospace.com/novartis-ag-japan-ordered-to-halt-business-for-15-days
Novartis AG Japan Ordered to Halt Business for 15 Days - BioSpace
novartis agjapanordered
https://www.biospace.com/ra-medical-systems-reports-2020-third-quarter-financial-results
Ra Medical Systems Reports 2020 Third Quarter Financial Results - BioSpace
Nov 13, 2020 - Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological...
medical systemsthird quarterfinancial resultsrareports
https://www.biospace.com/b-christopher-reeve-foundation-b-awards-close-to-2-million-in-individual-research-grants
Christopher Reeve Foundation Awards Close To $2 Million In Individual Research Grants - BioSpace
https://www.biospace.com/briacell-announces-collaboration-with-the-national-cancer-institute
BriaCell Announces Collaboration with the National Cancer Institute - BioSpace
Nov 10, 2020 - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF ) , a clinical-stage biotechnology company specializing in targeted...
national cancer institutecollaboration withannouncesbiospace
https://www.biospace.com/adela-appoints-precision-medicine-veteran-lisa-alderson-as-ceo
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO - BioSpace
Dec 15, 2023 - Adela, Inc. announced the appointment of Lisa Alderson as Chief Executive Officer, following an extensive, nationwide search.
precision medicineadelaveteranlisaalderson
https://www.biospace.com/roche-s-tamiflu-gets-eu-approval-for-use-on-children
Roche's Tamiflu Gets EU Approval For Use On Children - BioSpace
for useon childrenrochetamiflugets
https://www.biospace.com/press-releases/genedx-to-participate-in-upcoming-investor-conferences
GeneDx to Participate in Upcoming Investor Conferences - BioSpace
to participateinvestor conferencesgenedxupcomingbiospace
https://www.biospace.com/atossa-genetics-inc-to-present-at-the-b-fsx-dallas-investor-conference-b
Atossa Genetics, Inc. to Present at the FSX Dallas Investor Conference - BioSpace
at the
https://www.biospace.com/quidel-reports-third-quarter-2019-financial-results
Quidel Reports Third Quarter 2019 Financial Results - BioSpace
Oct 30, 2019 - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced...
third quarterfinancial resultsquidelreportsbiospace
https://www.biospace.com/press-releases/west-to-host-fourth-quarter-and-full-year-2024-conference-call
West to Host Fourth-Quarter and Full-Year 2024 Conference Call - BioSpace
west tofourth quarter
https://www.biospace.com/arena-announces-corporate-update-and-reports-first-quarter-2020-financial-results
Arena Announces Corporate Update and Reports First Quarter 2020 Financial Results - BioSpace
May 8, 2020 - Arena Pharmaceuticals, Inc. provided a corporate update and reported financial results for the first quarter ended March 31, 2020.
corporate update
https://www.biospace.com/medexus-schedules-fiscal-year-2021-conference-call
Medexus Schedules Fiscal Year 2021 Conference Call - BioSpace
Oct 9, 2024 - Medexus Pharmaceuticals Inc. today announced that it plans to host a conference call at 8:00 AM Eastern Time on Thursday, June 17, 2021 to discuss the...
fiscal yearconference callmedexusschedulesbiospace
https://www.biospace.com/urogen-pharma-to-host-ugn-102-data-event-on-july-27-2023
UroGen Pharma to Host UGN-102 Data Event on July 27, 2023 - BioSpace
Jul 6, 2023 - UroGen Pharma Ltd. today announced that it will host a data event on Thursday, July 27th, 2023 at 10:00 a.m. Eastern Time.
https://www.biospace.com/ait-laboratories-moving-headquarters-to-indianapolis-adding-160-jobs
AIT Laboratories Moving Headquarters To Indianapolis, Adding 160 Jobs - BioSpace
aitlaboratoriesmovingheadquartersindianapolis
https://www.biospace.com/biotech-issue-on-agenda-s-f-supervisor-wants-to-exempt-firms-from-payroll-tax
Biotech Issue On Agenda; S.F. Supervisor Wants To Exempt Firms From Payroll Tax - BioSpace
https://www.biospace.com/press-releases/verrica-pharmaceuticals-appoints-gavin-corcoran-m-d-to-its-board-of-directors
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - BioSpace
https://www.biospace.com/mergers-acquisitions
Mergers & acquisitions - BioSpace
mergers acquisitionsbiospace
https://www.biospace.com/national-brain-tumor-society-statement-on-senate-glioblastoma-day-awareness-resolution
National Brain Tumor Society Statement on Senate Glioblastoma Day Awareness Resolution - BioSpace
May 20, 2019 - National Brain Tumor Society is proud to announce its endorsement of a bipartisan resolution introduced on May 16, 2019, by U.S. Senator Lindsey Graham, with...
national brain tumor society
https://www.biospace.com/chemocentryx-inc-to-present-at-two-upcoming-investor-conferences-653714
ChemoCentryx, Inc. To Present At Two Upcoming Investor Conferences - BioSpace
investor conferencesincpresenttwoupcoming
https://www.biospace.com/oventus-release-aussie-first-on-snoring-on-world-stage
Oventus Release: Aussie First On Snoring On World Stage - BioSpace
world stagereleaseaussiefirstsnoring
https://www.biospace.com/clofarabine-promising-for-relapsed-or-refractory-pediatric-acute-leukemia
Clofarabine Promising For Relapsed Or Refractory Pediatric Acute Leukemia - BioSpace
acute leukemiapromisingrelapsedrefractorypediatric
https://www.biospace.com/ptc-therapeutics-provides-corporate-update-and-reports-third-quarter-financial-results
PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results - BioSpace
Oct 26, 2023 - PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the third quarter ending September 30, 2023.
ptc therapeuticscorporate update
https://patternofusa.com/2025/10/30/nearly-one-third-exploring-employment-opportunities-beyond-the-united-states-according-to-biospace-research/
Nearly One-Third Exploring Employment Opportunities Beyond the United States, According to BioSpace...
Nov 3, 2025 - Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to a BioSpace LinkedIn poll. Career...
the united states
https://www.biospace.com/cytosorbents-to-present-at-the-jefferies-virtual-london-healthcare-conference
CytoSorbents to Present at the Jefferies Virtual London Healthcare Conference - BioSpace
Nov 12, 2020 - CytoSorbents Corporation announced that the Company will present an overview of the company at the Jefferies Virtual London Healthcare Conference on Tuesday,...
at thehealthcare conferencepresent
https://www.biospace.com/antibody-fragments-market-segmentation-and-region-wise-outlook
Antibody Fragments Market: Segmentation & Region-wise Outlook - BioSpace
Dec 9, 2020 - Whole antibodies have grabbed a significant share of the global sales revenue as well as the volume of the biopharmaceuticals market.
market segmentationregion wiseantibodyfragmentsoutlook
https://www.biospace.com/medicare-to-cover-sex-performance-drugs
Medicare To Cover Sex Performance Drugs - BioSpace
medicarecoversexperformancedrugs
https://www.biospace.com/chief-executive-officer-patrik-dahlen-buys-immunovia-warrants
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants - BioSpace
Jan 19, 2021 - Immunovia AB, ("Immunovia") announces today that Patrik Dahlen , CEO of Immunovia, has purchased 250,000 warrants of the 2020/2024 scheme for approximately 400...
chief executive officerpatrikbuyswarrantsbiospace
https://www.biospace.com/neovasc-announces-extension-to-regain-compliance-with-nasdaq-minimum-bid-price-rule
Neovasc Announces Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule - BioSpace
Sep 11, 2018 - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement...
https://www.biospace.com/jazz-pharmaceuticals-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-248221-and-source-newsjoblink-font-color
Jazz Pharmaceuticals, Inc. (JOBS) Announces $26.0 Million Registered Direct Offering - BioSpace
jazz pharmaceuticals
https://www.biospace.com/invea-therapeutics-research-to-be-showcased-at-the-prestigious-2023-ddw-meeting
Invea Therapeutics Research to be Showcased at the Prestigious 2023 DDW Meeting - BioSpace
Apr 26, 2023 - Invea Therapeutics today announced the acceptance of two abstracts for oral presentations at the upcoming Digestive Disease Week (DDW) Annual Meeting.
https://www.biospace.com/press-releases/daxor-corporation-expands-blood-volume-analysis-technology-to-major-new-jersey-hospitals
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals - BioSpace
https://www.biospace.com/b-aflac-incorporated-b-to-release-third-quarter-results-on-october-24-2005
Aflac Incorporated To Release Third Quarter Results On October 24, 2005 - BioSpace
third quarter
https://www.biospace.com/pascal-biosciences-product-announcements
Pascal Biosciences Discovers a Cannabinoid That Combats Coronavirus - BioSpace
Jul 14, 2020 - SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 14, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the...
pascalbiosciencesdiscoverscannabinoidcombats
https://culturezonecolorado.com/article/864308022-catalyst-pharmaceuticals-recognized-among-biospace-2026-best-places-to-work
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work | Culture Zone Colorado
best places to work
https://www.biospace.com/sotera-health-announces-second-quarter-2023-earnings-release-date
Sotera Health Announces Second-Quarter 2023 Earnings Release Date - BioSpace
Jul 18, 2023 - Sotera Health Company (Nasdaq: SHC) today announced its plans to release its financial results for the second-quarter ended June 30, 2023 before the market...
sotera healthsecond quarterearnings releaseannouncesdate
https://www.biospace.com/adamis-pharmaceuticals-describes-planned-response-to-zimhi-complete-response-letter
Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response Letter - BioSpace
Dec 1, 2020 - Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced a planned response to a Complete Response Letter (CRL) from the U.S. Food and Drug...
pharmaceuticalsdescribesplannedresponsecomplete
https://www.biospace.com/amdl-inc-announces-launch-of-antibiotic-levofloxacin-in-china
AMDL, Inc. Announces Launch Of Antibiotic Levofloxacin In China - BioSpace
in chinaincannounceslaunchantibiotic
https://www.biospace.com/quest-pharmatech-inc-announces-the-passing-of-one-of-its-directors-299390
Quest PharmaTech Inc. Announces the Passing of One of its Directors - BioSpace
the passingquestpharmatechincannounces
https://www.biostaffic.com/company/biospace
BioSpace Careers - Jobs In BioSpace - Biostaffic.com
Explore BioSpace Openings Across Different Locations on Biostaffic. Get the inside scoop of BioSpace on jobs, salaries, top office locations, and insights.
jobs inbiospacecareers
https://www.biospace.com/roche-comments-on-impact-of-customer-s-recent-clinical-results
Roche Comments On Impact Of Customer's Recent Clinical Results - BioSpace
on impactclinical resultsrochecomments
https://www.biospace.com/study-indicates-superiority-of-veraform-marker-over-clips-during-breast-cancer-surgery
Study Indicates Superiority of VeraForm Marker Over Clips During Breast Cancer Surgery - BioSpace
Jul 24, 2023 - A recent peer-reviewed study published in the American Journal of Clinical Oncology demonstrates tumor bed delineation superiority of Videra Surgical's...
https://www.biospace.com/silk-road-medical-to-present-at-the-bofa-securities-2023-healthcare-conference
Silk Road Medical to Present at the BofA Securities 2023 Healthcare Conference - BioSpace
Apr 26, 2023 - Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will...
https://www.biospace.com/merge-healthcare-named-a-leading-vendor-in-b-klas-2015-b-midterm-performance-review
Merge Healthcare Named A Leading Vendor In KLAS 2015 Midterm Performance Review - BioSpace
https://www.biospace.com/b-icu-medical-inc-b-announces-time-of-earnings-call65412
ICU Medical, Inc. Announces Time Of Earnings Call - BioSpace
icu medicalearnings callincannouncestime
https://www.biospace.com/bluebird-bio-announces-november-investor-events
bluebird bio Announces November Investor Events - BioSpace
Nov 10, 2020 - bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the following upcoming investor conferences: Cowen...
investor eventsbluebirdbioannouncesnovember
https://newmexicobusinesstoday.com/article/864308371-protara-therapeutics-named-a-2026-best-places-to-work-winner-by-biospace
Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace | New Mexico Business Today
https://www.biospace.com/orchard-therapeutics-announces-new-clinical-and-pre-clinical-data-at-asgct-2023
Orchard Therapeutics Announces New Clinical and Pre-clinical Data at ASGCT 2023 - BioSpace
May 3, 2023 - Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced six presentations from across its hematopoietic stem cell (HSC) gene therapy...
https://www.biospace.com/biotech-in-demand-job-genetic-counselor
Biotech In-Demand Job: Genetic Counselor - BioSpace
Oct 14, 2019 - Our recent article describing six prominent careers in the biopharma industry was well-received by both college students and current biopharma professionals....
in demandgenetic counselorbiotechjobbiospace
https://moldovaculturalpost.com/article/864308022-catalyst-pharmaceuticals-recognized-among-biospace-2026-best-places-to-work
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work | Moldova Cultural Post
best places to work
https://www.biospace.com/promis-neurosciences-announces-publication-on-novel-target-for-als
ProMIS Neurosciences Announces Publication on Novel Target for ALS - BioSpace
Dec 20, 2023 - ProMIS Neurosciences Inc. today announced a publication identifying Receptor for Activated C-Kinase 1 (RACK1) as a novel misfolded protein target for ALS and...
promisneurosciencesannouncespublicationnovel
https://www.biospace.com/schizophrenia
Schizophrenia - BioSpace
schizophreniabiospace
https://www.biospace.com/easton-pharmaceuticals-letter-to-shareholders
Easton Pharmaceuticals Letter To Shareholders - BioSpace
letter to shareholderseastonpharmaceuticalsbiospace
https://www.biospace.com/xtant-medical-to-present-at-the-canaccord-musculoskeletal-conference-on-march-7-2023
Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 7, 2023 - BioSpace
Feb 28, 2023 - Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...
https://www.biospace.com/antares-pharma-inc-receives-milestone-payment-from-bradley-pharmaceuticals
Antares Pharma, Inc. Receives Milestone Payment From Bradley Pharmaceuticals - BioSpace
antarespharmaincreceivesmilestone
https://www.biospace.com/maplight-therapeutics-appoints-charmaine-lykins-as-chief-commercial-officer
Maplight Therapeutics Appoints Charmaine Lykins as Chief Commercial Officer - BioSpace
Apr 12, 2023 - MapLight Therapeutics announced the appointment of Charmaine Lykins, MBA, as chief commercial officer, effective April 3,2023.
maplighttherapeuticscharmainechiefcommercial
https://www.biospace.com/lensar-reports-third-quarter-2023-results-and-provides-business-update
LENSAR Reports Third Quarter 2023 Results and Provides Business Update - BioSpace
Nov 10, 2023 - LENSAR, Inc. announced financial results for the quarter ended September 30, 2023 and provided an update on key operational initiatives.
third quarterbusiness updatelensarreports
https://www.biospace.com/technology-predicts-outcome-of-child-heart-surgery
Technology Predicts Outcome Of Child Heart Surgery - BioSpace
heart surgerytechnologypredictsoutcomechild
https://www.biospace.com/epizyme-reacquires-rights-to-cancer-drug-from-eisai-company-in-deal-worth-110-million
Epizyme Reacquires Rights to Cancer Drug From Eisai Company in Deal Worth $110 Million - BioSpace
https://www.biospace.com/bandgrip-joins-forces-with-medline
Bandgrip Joins Forces With Medline - BioSpace
Apr 27, 2020 - Exclusive Partnership Extends Reach of Surgical Wound Closure Innovation, Eliminates In-Office Removal Requirements
joinsforcesmedlinebiospace
https://www.biospace.com/manufacturing
Manufacturing - BioSpace
manufacturingbiospace
https://www.biospace.com/serotonin-reducing-mutation-tied-to-major-depression
Serotonin-reducing Mutation Tied To Major Depression - BioSpace
major depressionserotoninreducingmutationtied
https://www.biospace.com/topical-drug-delivery-market-size-to-reach-usd-238-38-billion-by-2033
Topical Drug Delivery Market Size to Reach USD 238.38 Billion By 2033 - BioSpace
https://www.biospace.com/parse-biosciences-launches-crispr-detect
Parse Biosciences Launches CRISPR Detect - BioSpace
Jun 8, 2023 - Parse Biosciences announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale.
parse biosciencescrispr detectlaunchesbiospace
https://www.biospace.com/neurocrine-biosciences-reports-first-quarter-2024-financial-results
Neurocrine Biosciences Reports First Quarter 2024 Financial Results - BioSpace
May 1, 2024 - Neurocrine Biosciences, Inc. announced its financial results for the first quarter ended March 31, 2024 and provided an update on its 2024 financial guidance.
first quarterfinancial resultsneurocrinebiosciencesreports
https://www.biospace.com/celgene-earnings-top-expectations-shares-jump
Celgene Earnings Top Expectations, Shares Jump - BioSpace
earningstopexpectationssharesjump
https://www.biospace.com/biopure-corporation-updates-regulatory-status-of-navy-s-proposed-resus-trauma-trial
Biopure Corporation Updates Regulatory Status Of Navy's Proposed 'RESUS' Trauma Trial - BioSpace
https://www.biospace.com/glaxo-pressured-by-spitzer-publishes-paxil-data
Glaxo, Pressured By Spitzer, Publishes Paxil Data - BioSpace
glaxopressuredspitzerpublishespaxil
https://www.biospace.com/amd-lasers-announces-free-global-dental-laser-certification-program
AMD LASERS Announces Free Global Dental Laser Certification Program - BioSpace
dental lasercertification programamdlasersannounces
https://www.biospace.com/fda-issues-draft-guidance-on-device-changes-that-warrant-new-premarket-review
FDA Issues Draft Guidance on Device Changes That Warrant New Premarket Review - BioSpace
https://www.biospace.com/hoya-vision-care-presents-b-hoya-eyegenius-b
Hoya Vision Care Presents Hoya EyeGenius - BioSpace
vision carehoyapresentsbiospace
https://www.biospace.com/bionomics-to-present-at-the-2024-bio-ceo-and-investor-conference
Bionomics to Present at the 2024 BIO CEO & Investor Conference - BioSpace
at theinvestor conferencepresent
https://www.culturetimesidaho.com/article/864308022-catalyst-pharmaceuticals-recognized-among-biospace-2026-best-places-to-work
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work | The Culture Times of...
best places to work
https://www.biospace.com/cp-kelco-a-huber-company-and-fluxome-sciences-join-forces-in-resveratrol
CP Kelco, a Huber Company and Fluxome Sciences Join Forces in Resveratrol - BioSpace
https://www.biospace.com/abbott-labs-under-pressure
Abbott Labs Under Pressure - BioSpace
abbott labsunder pressurebiospace
https://www.biospace.com/nick-paul-taylor
Nick Paul Taylor - BioSpace
Sep 3, 2024 - Nick is a freelance writer who has been reporting on the global life sciences industry since 2008.
nick paul taylorbiospace
https://www.biospace.com/microarray-market-size-worth-usd-8-17-billion-in-2030-emergen-research
Microarray Market Size Worth USD 8.17 Billion in 2030 | Emergen Research - BioSpace
Jul 12, 2022 - The global microarray market size was USD 3.99 Billion in 2021 and is expected to register a revenue CAGR of 8.31% during the forecast period, according to...
https://www.biospace.com/oncternal-therapeutics-to-present-at-stifel-virtual-healthcare-conference
Oncternal Therapeutics to Present at Stifel Virtual Healthcare Conference - BioSpace
Nov 10, 2020 - Oncternal Therapeutics (Nasdaq: ONCT), today announced that James Breitmeyer, M.D., Ph.D., President and Chief Executive Officer, will present a company...
virtual healthcaretherapeuticspresentstifelconference
https://www.biospace.com/behavioral-health-experts-to-address-technology-and-amp-addiction
Behavioral Health Experts To Address Technology & Addiction - BioSpace
Jun 20, 2019 - C4 Recovery Foundation, in collaboration with The Center for Internet and Technology Addiction and GLOO, has gathered top experts in the field of technology...
behavioral healthtechnology addictionexpertsaddressbiospace
https://www.biospace.com/cellnetix-selects-proscia-to-deliver-new-standard-of-excellence-in-pathology
CellNetix Selects Proscia To Deliver New Standard Of Excellence In Pathology - BioSpace
Dec 6, 2023 - Modernizing the 150-year-old microscope-based practice with digital innovation
standard of excellence
https://www.biospace.com/hpfy-scholarship-deadline-fast-approaching
HPFY Scholarship Deadline Fast Approaching - BioSpace
Jun 6, 2019 - At HPFY corporate social responsibility is of great importance. They have successfully launched 27 Giving Days till date, donating over $63k to global causes.
scholarshipdeadlinefastapproachingbiospace
https://www.biospace.com/press-releases/thermo-fisher-scientific-reports-first-quarter-2025-results
Thermo Fisher Scientific Reports First Quarter 2025 Results - BioSpace
thermo fisher scientificfirst quarterreportsresultsbiospace
https://www.biospace.com/press-releases/alira-health-unveils-2024-report-on-antibody-drug-conjugates-market
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market - BioSpace
antibody drug conjugatesalira healthunveilsreport
https://www.biospace.com/proqr-therapeutics-b-v-remembers-co-founder-b-henri-termeer-b-after-his-unexpected-passing
ProQR Therapeutics B.V. Remembers Co-Founder Henri Termeer After His Unexpected Passing - BioSpace
https://www.biospace.com/align-technology-inc-announces-retirement-of-b-david-e-collins-b-from-board-of-directors
Align Technology, Inc. Announces Retirement Of David E. Collins From Board Of Directors - BioSpace
https://newjerseyhealthreporter.com/article/864308022-catalyst-pharmaceuticals-recognized-among-biospace-2026-best-places-to-work
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work | New Jersey Health...
best places to work
https://www.biospace.com/fundamental-pharma-appoints-industry-veteran-dr-lorenz-mayr-as-non-executive-director
FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director - BioSpace
Mar 20, 2024 - FundaMental Pharma GmbH announced the appointment of Dr. Lorenz Mayr to its Board of Directors.
https://www.biospace.com/heat-biologics-provides-third-quarter-2020-business-update
Heat Biologics Provides Third Quarter 2020 Business Update - BioSpace
Nov 9, 2020 - Heat Biologics, Inc. (NASDAQ:HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system,...
third quarterbusiness updateheatbiologicsprovides
https://www.biospace.com/drug-development/viridian-turns-green-again-as-new-phase-3-data-vindicate-thyroid-eye-disease-drug
Viridian turns green again as new Phase 3 data vindicate thyroid eye disease drug - BioSpace
May 6, 2026 - Viridian Therapeutics’ elegrobart normalized the degree of eye protrusion and improved double vision in a Phase 3 study. The company plans to file for approval...
https://www.biospace.com/new-help-for-urinary-dysfunction
New Help For Urinary Dysfunction - BioSpace
help fornewurinarydysfunctionbiospace
https://www.biospace.com/a-pfizer-initiative-leads-to-second-career-for-former-employee
Pfizer Initiative Leads to Second Career for Former Employee - BioSpace
Jan 4, 2019 - In 2013 Pfizer launched its Dare to Try initiative, a project designed to foster internal innovation at the pharma giant. It was an effort that encouraged...
initiative leadssecond careerformer employeepfizerbiospace
https://www.biospace.com/press-releases/aethlon-medical-to-participate-in-the-2024-maxim-healthcare-virtual-summit
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit - BioSpace
to participatein the
https://www.biospace.com/job-creations
Job creations - BioSpace
jobcreationsbiospace
https://www.biospace.com/amneal-to-report-third-quarter-2019-results-on-november-6-2019
Amneal to Report Third Quarter 2019 Results on November 6, 2019 - BioSpace
Oct 9, 2019 - The Company will host a conference call and live webcast with the investment community at 8:30 a.m., Eastern Time on November 6, 2019.
third quarteramnealreport
https://www.biospace.com/avero-diagnostics-now-offering-covid-19-testing
Avero Diagnostics Now Offering COVID-19 Testing - BioSpace
Jul 10, 2024 - Avero Diagnostics, a physician-owned laboratory, is now providing molecular testing for COVID-19.
now offeringdiagnosticscovidtestingbiospace
https://www.biospace.com/b-genesis-healthcare-b-to-present-at-b-friedman-billings-ramsey-b-growth-investor-conference
Genesis HealthCare To Present At Friedman, Billings, Ramsey Growth Investor Conference - BioSpace
https://www.biospace.com/ats-medical-inc-announces-fda-approval-of-the-ats-3f-aortic-bioprosthesis
ATS Medical, Inc. Announces FDA Approval of the ATS 3f Aortic Bioprosthesis - BioSpace
fda approval
https://www.biospace.com/vertex-to-announce-second-quarter-2018-financial-results-on-july-25
Vertex to Announce Second Quarter 2018 Financial Results on July 25 - BioSpace
Jul 13, 2018 - Vertex Pharmaceuticals Incorporated will report its second quarter 2018 financial results on Wednesday, July 25, 2018 after the financial markets close.
to announcesecond quarter